Cesca Therapeutics FQ2 results

• Cesca Therapeutics (KOOL -5.9%) FQ2 results: Revenues: $4.6M (+2.2%); COGS: $3.1M (+14.8%); Operating Expense: $5.9M (+73.5%); Net Loss: ($4.4M) (-175.0%); Loss Per Share: ($0.11) (-10.0%); Quick Assets: $8.4M (-43.2%); CF Ops: ($5.9M) (-37.2%).
• No guidance given.